Last reviewed · How we verify

NCT06826092

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Recruiting now Phase 2 Last updated 13 February 2025
What this trial tests

Phase 2 trial testing Metformin Pill in Progression-Free Survival in 110 participants. Currently enrolling.

Timeline
31 October 2022
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorKaohsiung Medical University Chung-Ho Memorial Hospital
PhasePhase 2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment110
Start date31 October 2022
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Who can join

Adults 20 to 90, any sex, with Progression-Free Survival. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate progression-free survival (PFS) in patients with metastatic colorectal cancer treated with chemotherapy FOLFIRI monotherapy or chemotherapy FOLFIRI combined with Metformin

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy.
    Zhang H, Fan J, Kong D, Sun Y, et al · · 2025 · cited 8× · PMID 41063213 · DOI 10.1186/s12943-025-02460-1

Verify or expand the search:

Other trials of Metformin Pill

Trials testing the same drug.

Other recruiting trials for Progression-Free Survival

Currently open trials in the same condition.

Other Kaohsiung Medical University Chung-Ho Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06826092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing